Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain MRI may spot troubled fetuses before birth

NCT ID NCT02229630

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a special brain MRI could predict which unborn babies with poor growth (intrauterine growth restriction) will have health problems after birth. Researchers scanned 82 fetuses before 32 weeks of pregnancy and compared the results to their health at delivery. The goal was to see if the scan could identify those at highest risk of complications like low Apgar scores or needing intensive care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify which growth-restricted fetuses are at highest risk, allowing earlier intervention.
What could go wrong
This is a small, observational study that only looks at whether MRI can predict outcomes. It does not test a treatment, so it may not change care directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

82 people

The number who actually took part.

Started

Mar 2015

Finished

Oct 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * single pregnancy * estimated foetal weight ≤ 5th percentile * agreeing to participate * women age ≥ 18 years of age, speaking and understanding French language * covered by the French social security system Exclusion Criteria: * foetal malformation or foetal karyotype abnormal * infectious foetopathy * multiple pregnancy * refusal to participate * pregnant women aged \< 18 years old * pregnant women not understanding or speaking French language * not covered by French social security * contraindication to MRI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnant women with foetuses presenting with intra-uterine growth restriction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Armand Trousseau

    Paris, 75012, France